Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
2
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
3
Monitoring, Reporting, and the Future of AI in Drug Diversion Prevention Programs
4
From Approval to Practice: Auvelity's Place in Alzheimer Disease Agitation Care
5